On 2024-05-20, SAB Biotherapeutics, Inc. (SABS) announced earnings per share of $-0.54 for the fiscal quarter ending 2024-03-31, beating the average analyst estimate of $-0.98.
The next expected annoucement date for quarterly earnings is 2024-08-19, with an average estimated earnings per share of $-1.02 for the fiscal quarter ending 2024-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-05-20 | 2024-03-31 | $-0.98 | $-0.54 |
| 2023-11-13 | 2023-09-30 | $-1.00 | $-1.00 |
| 2023-08-21 | 2023-06-30 | $-1.60 | $-1.40 |
| 2023-05-16 | 2023-03-31 | $-0.80 | $-1.50 |
| 2022-11-15 | 2022-09-30 | $-1.40 | $-1.60 |
| 2022-08-10 | 2022-06-30 | $-1.30 | $-1.10 |
| 2022-05-12 | 2022-03-31 | $-1.20 | $-1.50 |
| 2021-11-22 | 2021-09-30 | $-0.60 | $-0.20 |